Marked for destruction: Newly developed compound triggers cancer cell death

Date:

May 24, 2012

Source:

Journal of Clinical Investigation

Summary:

Scientists have developed a compound that enhance cell death in cancer cells.

Share:

Total shares:

FULL STORY

The BCL-2 protein family plays a large role in determining whether cancer cells survive in response to therapy or undergo a form of cell death known as apoptosis. Cells are pressured toward apoptosis by expression of pro-apoptotic BCL-2 proteins. However, cancer cells respond to therapy by increasing expression of anti-apoptotic proteins, which bind and neutralize pro-apoptotic family members and mediate therapeutic resistance.

Therefore, development of therapeutic strategies to neutralize resistance to apoptosis will be critical to clinical improvements.

A research group from the Dana-Farber Cancer Institute, led by Dr. Loren Walensky, developed a compound modeled directly from the pro-apoptotic the death domain of BCL-2, the BIM BH3 domain. This compound, known as a stapled BIM BH3 peptide, was found to competitively bind with anti-apoptotic proteins and led to enhanced apoptosis in cancer cells. They also showed that tumor growth in mice was suppressed by the stapled BIM BH3 compound and that the new compound worked synergistically with other with pharmaceutical agents that promote apoptosis.

The potential therapeutic effects of stapled BIM BH3 were further shown by activation of cell death in an acute myeloid leukemia tumor model in mice with little side effects on surrounding tissue. Their study presents a new formulation of a BH3 mimetic that has broad BCL-2 family targeting and may provide significant clinical benefit.

July 31, 2015  School is just around the corner, which means backpacks and packed lunches await your children. One expert offers tips for parents to promote healthy dental habits while away from ... read more

July 29, 2015  By blocking the expression of a certain gene in patients, researchers have contributed to the demonstration of great decreases in the concentration of triglycerides in their ... read more

July 29, 2015  Viewing aquarium displays led to noticeable reductions in blood pressure and heart rate, a research team found in the first study of its kind. They also noted that higher numbers of fish helped to ... read more

June 26, 2014  A group of molecules that help cause apoptosis in lung cancer cells have been discovered by scientists. One of the characteristics of lung cancer is the dysregulation of apoptosis, or regulated cell ... read more

June 17, 2014  A compound initially developed as a cholesterol-fighting molecule not only halts the progression of breast cancer, but also can kill the cancerous cells, research confirms. "The compound ... read more

Apr. 21, 2013  Scientists have tailor-made a new chemical compound that blocks a protein that has been linked to poor responses to treatment in cancer patients. The development of the compound, called WEHI-539, is ... read more

May 31, 2012  Researchers have devised a strategy to directly activate a natural "death" protein, triggering the self-destruction of cells -- which could lead to new possibilities for designing cancer ... read more